Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 04, 2018 10:01 ET | Source: Obalon Therapeutics, Inc.

Obalon Schedules First Quarter 2018 Financial Results Conference Call for May 10, 2018 at 5:00 p.m. Eastern Time

SAN DIEGO, May 04, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
March 05, 2018 15:01 ET | Source: Obalon Therapeutics, Inc.

Obalon Announces Fourth Quarter and Full Year 2017 Financial Results

SAN DIEGO, March 05, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
March 05, 2018 09:01 ET | Source: Obalon Therapeutics, Inc.

Obalon Schedules Fourth Quarter and Year End 2017 Financial Results Conference Call for March 5, 2018 at 5:00 p.m. Eastern Time

SAN DIEGO, March 05, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
February 20, 2018 07:01 ET | Source: Obalon Therapeutics, Inc.

Obalon’s Audit Committee Investigation of Whistleblower Allegation Finds Complaint Meritless

SAN DIEGO, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN) today announced the Audit Committee has completed its investigation into a purported whistleblower complaint and...
January 23, 2018 09:13 ET | Source: Obalon Therapeutics, Inc.

Obalon Announces Termination of Public Offering of Common Stock

SAN DIEGO, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (the “Company” or “Obalon”) (NASDAQ:OBLN) today announced the termination of the underwriting agreement and cancellation of its...
January 18, 2018 22:00 ET | Source: Obalon Therapeutics, Inc.

Obalon Therapeutics Prices Public Offering of Common Stock

SAN DIEGO, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical device company with the first and only FDA-approved swallowable, gas-filled...
January 16, 2018 16:01 ET | Source: Obalon Therapeutics, Inc.

Obalon Therapeutics Announces Proposed Public Offering of Common Stock

SAN DIEGO, Jan. 16, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical device company with the first and only FDA-approved swallowable, gas-filled...
January 05, 2018 08:00 ET | Source: Obalon Therapeutics, Inc.

Obalon Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter and Full Year 2017

SAN DIEGO, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN) today reported that it achieved preliminary, unaudited revenue of approximately $3.9 million for the fourth...
January 04, 2018 17:15 ET | Source: Obalon Therapeutics, Inc.

Obalon Schedules Fourth Quarter and Full Year 2017 Preliminary, Unaudited Revenue and Business Update Conference Call for January 5, 2018 at 8:30 a.m. Eastern Time

SAN DIEGO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
November 06, 2017 08:46 ET | Source: Obalon Therapeutics, Inc.

Obalon Announces Upcoming Conference Presentations

SAN DIEGO, Nov. 06, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...